Byhealth Co., Ltd

SZSE:300146 Stock Report

Market Cap: CN¥19.5b

Byhealth Future Growth

Future criteria checks 1/6

Byhealth is forecast to grow earnings and revenue by 18.8% and 9% per annum respectively. EPS is expected to grow by 18.4% per annum. Return on equity is forecast to be 8.6% in 3 years.

Key information

18.8%

Earnings growth rate

18.35%

EPS growth rate

Personal Products earnings growth33.8%
Revenue growth rate9.0%
Future return on equity8.62%
Analyst coverage

Good

Last updated27 Nov 2025

Recent future growth updates

Recent updates

Byhealth's (SZSE:300146) Weak Earnings May Only Reveal A Part Of The Whole Picture

Mar 28
Byhealth's (SZSE:300146) Weak Earnings May Only Reveal A Part Of The Whole Picture

Byhealth Co., Ltd (SZSE:300146) Doing What It Can To Lift Shares

Mar 10
Byhealth Co., Ltd (SZSE:300146) Doing What It Can To Lift Shares

Be Wary Of Byhealth (SZSE:300146) And Its Returns On Capital

Jan 07
Be Wary Of Byhealth (SZSE:300146) And Its Returns On Capital

These 4 Measures Indicate That Byhealth (SZSE:300146) Is Using Debt Reasonably Well

Dec 03
These 4 Measures Indicate That Byhealth (SZSE:300146) Is Using Debt Reasonably Well

Byhealth Co., Ltd (SZSE:300146) Surges 32% Yet Its Low P/E Is No Reason For Excitement

Sep 30
Byhealth Co., Ltd (SZSE:300146) Surges 32% Yet Its Low P/E Is No Reason For Excitement

Byhealth (SZSE:300146) Will Want To Turn Around Its Return Trends

Sep 22
Byhealth (SZSE:300146) Will Want To Turn Around Its Return Trends

Things Look Grim For Byhealth Co., Ltd (SZSE:300146) After Today's Downgrade

Aug 11
Things Look Grim For Byhealth Co., Ltd (SZSE:300146) After Today's Downgrade

Investors Don't See Light At End Of Byhealth Co., Ltd's (SZSE:300146) Tunnel

Jul 26
Investors Don't See Light At End Of Byhealth Co., Ltd's (SZSE:300146) Tunnel

Byhealth (SZSE:300146) Could Be Struggling To Allocate Capital

May 23
Byhealth (SZSE:300146) Could Be Struggling To Allocate Capital

We Think That There Are Issues Underlying Byhealth's (SZSE:300146) Earnings

Mar 25
We Think That There Are Issues Underlying Byhealth's (SZSE:300146) Earnings

Byhealth Co., Ltd (SZSE:300146) Just Reported Earnings, And Analysts Cut Their Target Price

Mar 23
Byhealth Co., Ltd (SZSE:300146) Just Reported Earnings, And Analysts Cut Their Target Price

Earnings and Revenue Growth Forecasts

SZSE:300146 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20277,4311,0711,5231,4568
12/31/20266,9449099071,1889
12/31/20256,362770-541,1559
9/30/20256,0206921,0771,266N/A
6/30/20255,7574988111,034N/A
3/31/20255,984381653899N/A
12/31/20246,838653380686N/A
9/30/20247,3587147391,046N/A
6/30/20248,4241,0929951,306N/A
3/31/20248,9451,4432231,535N/A
1/1/20249,4071,7467942,051N/A
9/30/20239,4841,8056661,938N/A
6/30/20239,2371,8838182,075N/A
3/31/20238,6891,7521,8332,090N/A
12/31/20227,8611,3861,1341,379N/A
9/30/20227,5631,5731,4041,645N/A
6/30/20227,4541,4311,1701,430N/A
3/31/20227,4891,6011,4681,721N/A
12/31/20217,4311,7541,5561,819N/A
9/30/20217,0911,7201,0001,267N/A
6/30/20217,1681,9341,2991,534N/A
3/31/20216,8221,8061,2361,573N/A
12/31/20206,0951,5241,2451,566N/A
9/30/20205,914-801,7332,039N/A
6/30/20205,417-2611,4851,821N/A
3/31/20205,186-3191,3191,576N/A
12/31/20195,262-3561,2051,537N/A
9/30/20195,3101,1328801,192N/A
6/30/20195,1511,161N/A1,238N/A
3/31/20194,8541,125N/A1,234N/A
12/31/20184,351999N/A1,349N/A
9/30/20184,1821,018N/A1,226N/A
6/30/20183,794885N/A1,084N/A
3/31/20183,442852N/A951N/A
12/31/20173,111763N/A954N/A
9/30/20172,747771N/A809N/A
6/30/20172,562759N/A772N/A
3/31/20172,389594N/A694N/A
12/31/20162,309535N/A685N/A
9/30/20162,398619N/A710N/A
6/30/20162,322577N/A583N/A
3/31/20162,344655N/A613N/A
12/31/20152,266635N/A635N/A
9/30/20152,101609N/A606N/A
6/30/20151,944566N/A624N/A
3/31/20151,806530N/A572N/A
12/31/20141,705503N/A561N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 300146's forecast earnings growth (18.8% per year) is above the savings rate (2.6%).

Earnings vs Market: 300146's earnings (18.8% per year) are forecast to grow slower than the CN market (27.2% per year).

High Growth Earnings: 300146's earnings are forecast to grow, but not significantly.

Revenue vs Market: 300146's revenue (9% per year) is forecast to grow slower than the CN market (14.6% per year).

High Growth Revenue: 300146's revenue (9% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 300146's Return on Equity is forecast to be low in 3 years time (8.6%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/12/14 06:03
End of Day Share Price 2025/12/12 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Byhealth Co., Ltd is covered by 24 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Feiyang YuanChina International Capital Corporation Limited
Wendan WangChina International Capital Corporation Limited
Wenbo ChenChina International Capital Corporation Limited